Nabitax-S Injection
Marketer
Narun Bharti Pvt Ltd
Salt Composition
Ceftriaxone (500mg) + Sulbactam (250mg)
Overview Nabitax-S Injection
Synergix-B Injection is a multi-component medication used to combat diverse bacterial infections. Its action inhibits microbial proliferation, thereby limiting infection spread. Administration must be overseen by a qualified medical practitioner. Adherence to the prescribed dosage schedule is crucial; completing the entire course is essential, even with symptom improvement. Premature cessation may compromise therapeutic efficacy. Commonly reported adverse effects include nausea, vomiting, diarrhea, and dyspepsia. Worsening side effects warrant immediate medical consultation. Seek immediate medical attention for allergic reactions (e.g., rash, pruritus, edema, dyspnea). Prior to initiating treatment, inform your physician of all current medications and health conditions. Consult your doctor before use during pregnancy or breastfeeding. Alcohol consumption should be avoided due to potential increased drowsiness. While generally not impairing driving ability, refrain from driving if experiencing somnolence or vertigo. Adequate rest, a nutritious diet, and sufficient hydration are recommended for optimal recovery. Your physician may order laboratory tests and imaging studies to assess treatment response.
Primary Ingredients of Nabitax-S Injection
No text was provided to rewrite.
Uses of Nabitax-S Injection
Infections caused by bacteria
Major Benefits of Nabitax-S Injection:
Administering this medication will be handled by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Nabitax-S Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Nabitax-S Injection:
Administering this medication will be performed by your physician or their designated nurse; self-medication is strictly prohibited.
How Nabitax-S Injection works:
Nabitax-S Injection merges Ceftriaxone, a bacterial growth inhibitor, with Sulbactam, a beta-lactamase inhibitor. Ceftriaxone's mechanism disrupts bacterial cell wall synthesis, vital for bacterial viability. Sulbactam counters bacterial resistance mechanisms, thereby bolstering Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concomitant use of Nabitax-S Injection and alcohol.
PregnancySAFE IF PRESCRIBED
The use of Nabitax-S Injection during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or absent negative impacts on fetal development; nevertheless, data from human trials are scarce.
Breast feedingCAUTION
Administering Nabitax-S Injection to breastfeeding mothers requires careful consideration. Mothers should discontinue breastfeeding throughout the course of treatment and until the medication is fully cleared from their system.
DrivingUNSAFE
Administering Nabitax-S Injection might reduce vigilance, impair vision, or induce drowsiness and dizziness. Driving should be avoided if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Nabitax-S Injection's use in patients suffering from renal impairment. Physician consultation is advised.
LiverCAUTION
Exercise caution when administering Nabitax-S Injection to individuals with severe hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Dosage alteration for Nabitax-S Injection is unnecessary in patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Nabitax-S Injection :
Omit a Nabitax-S Injection dose? Seek your physician's advice.
Facts to Know About Nabitax-S Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |



